Latest Breaking News On - Patients experiencing symptomatic atrial - Page 1 : comparemela.com

An analysis of data from the NODE-303 trial provides insight into the effects of etripamil nasal spray in people with atrial fibrillation with rapid ventricular rates.

Paul dorianJoseph olivetoMilestone pharmaceuticals incUniversity of torontoMilestone pharmaceuticalsDrug administrationHeart rhythmChief executive officerMilestone pharmaNew drug applicationEtripamil nasal sprayVentricular ratePatients experiencing symptomatic atrial